MENU
SBIO
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

SBIO stock forecast, quote, news & analysis

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network® Medical Breakthroughs Index... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
SBIO
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for SBIO with price predictions
Oct 19, 2026

SBIO's Indicator enters downward trend

The Aroon Indicator for SBIO entered a downward trend on October 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 208 similar instances where the Aroon Indicator formed such a pattern. In 187 of the 208 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SBIO's RSI Oscillator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

Following a +0.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBIO advanced for three days, in 284 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

SBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are BioCryst Pharmaceuticals (NASDAQ:BCRX), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network® Medical Breakthroughs Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Market Cap

The average market capitalization across the ALPS Medical Breakthroughs ETF (SBIO) ETF is 1.97B. The market cap for tickers in the group ranges from 56.88M to 5.8B. TVTX holds the highest valuation in this group at 5.8B. The lowest valued company is TENX at 56.88M.

High and low price notable news

The average weekly price growth across all stocks in the ALPS Medical Breakthroughs ETF (SBIO) ETF was -3%. For the same ETF, the average monthly price growth was -16%, and the average quarterly price growth was -7%. IRON experienced the highest price growth at 31%, while UPB experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the ALPS Medical Breakthroughs ETF (SBIO) ETF was 28%. For the same stocks of the ETF, the average monthly volume growth was -54% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 40
Price Growth Rating: 50
SMR Rating: 93
Profit Risk Rating: 88
Seasonality Score: 10 (-100 ... +100)
SBIO's Indicator enters downward trend